TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) just unveiled an update.
Shanghai Bio-heart Biological Technology Co., Ltd. has announced a board meeting scheduled for August 26, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the possibility of declaring an interim dividend, which could have implications for the company’s financial strategy and shareholder returns.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology sector. The company focuses on developing biological technologies and solutions, with a market presence in Hong Kong as indicated by its stock listing.
Average Trading Volume: 1,013,046
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.72B
See more insights into 2185 stock on TipRanks’ Stock Analysis page.